Abstract:Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue.Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated.Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH.Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes.Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety. Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue. Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated. Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH. Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes. Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety.

Experimental Study on the Vitrification and Xenotransplantation of Human Ovarian Tissue

Morphology and Cell Proliferation Evaluation of Follicles from Cryopreserved Human Ovarian Tissue by Vitrifiction and Slow-cooling

[Morphology and cell proliferation evaluation of follicles from cryopreserved human ovarian tissue by vitrification].

Influencing factors and research progress of the human ovarian tissue xenotransplantation

Assessment of the Effect of Different Vitrification Solutions on Human Ovarian Tissue after Short-Term Xenotransplantation Onto the Chick Embryo Chorioallantoic Membrane

Comparison between Slow Freezing and Vitrification for Human Ovarian Tissue Cryopreservation and Xenotransplantation

Novel Needle Immersed Vitrification: a Practical and Convenient Method with Potential Advantages in Mouse and Human Ovarian Tissue Cryopreservation

Modified Vitrification Method for Cryopreservation of Human Ovarian Tissues

Fertility restore of allotransplantation of vitrified-warmed junvenile ovaries treated with a modified vitrification solution

Vitrification freezing of large ovarian tissue in the human body

Effects of Two Cryoprotectants on Mouse Ovarian Tissue after Vitrification

Effects of Cryopreservation on Mouse Ovarian Tissue after Vitrification

Cryopreservation of Human Ovarian Tissue Using the Silver Closed Vitrification System.

Preservation of mouse ovarian tissue follicle morphology and ultra-structure after vitrifying in biotechnological protocols

Experimental Study on Xenotransplantation of Sheep Ovarian Tissue Cryopreserved by Vitrification

Cryopreservation of Human Ovarian Tissue: Comparison of Novel Direct Cover Vitrification and Conventional Vitrification

The Revascularization and Follicular Survival of Mouse Ovarian Grafts Treated with FSH During Cryopreservation by Vitrification.

Comparison of short-term transplantation effect of different vitrification solution on human ovarian tissue

Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis

The investigation of xenografted human fetal ovarian tissue

Human Ovarian Cortex Cryopreservation and Banking